Healthcare Infection Control Practices Advisory Committee (HICPAC), 11977 [2019-06088]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 61 / Friday, March 29, 2019 / Notices
possession are subject to being x-rayed
and inspected. Federal law prohibits the
knowing possession or the causing to be
present of firearms, explosives and other
dangerous weapons and illegal
substances.
Purpose: This committee is charged
with providing advice and making
recommendations to the Secretary,
Department of Health and Human
Services; the Director, CDC; and the
Director, NCHS, regarding the scientific
and technical program goals and
objectives, strategies, and priorities of
NCHS.
Matters To Be Considered: Day 1
meeting agenda includes welcome
remarks and a Center update by NCHS
leadership; update on the release of
linked data files; update on the
Implementation of the Redesigned
National Health Interview Survey;
report by the National Health Interview
Survey Redesign Key Health Indicators
Workgroup; update on Patient Centered
Outcomes Research Trust Fund Projects;
Day 2 meeting agenda includes update
on Comparability Study for OPIOID
Questions; an update on NCHS
Statistics Maternal Mortality Data.
Agenda items are subject to change as
priorities dictate.
Chief Operating Officer, Centers for
Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–06087 Filed 3–28–19; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
jbell on DSK30RV082PROD with NOTICES
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). This meeting is open to the
public, is limited only by room seating
SUMMARY:
VerDate Sep<11>2014
17:48 Mar 28, 2019
Jkt 247001
available, (120). The public is also
welcome to listen to the meeting via
teleconference at 888–455–9748,
passcode: 4373458; 100 teleconference
lines are available. Time will be
available for public comment. The
public is welcome to submit written
comments in advance of the meeting.
Comments should be submitted in
writing by email to the contact person
listed below. The deadline for receipt of
written public comment is May 2, 2019.
All requests must contain the name,
address, and organizational affiliation of
the speaker, as well as the topic being
addressed. Written comments should
not exceed one single-spaced typed page
in length and delivered in 3 minutes or
less. Members of the public who wish
to provide public comments should
plan to attend the public comment
session at the start time listed. Please
note that the public comment period
may end before the time indicated,
following the last call for comments.
Written comments received in advance
of the meeting will be included in the
official record of the meeting.
Registration is required to attend in
person or on the phone. Interested
parties must be processed in accordance
with established federal policies and
procedures and may register at https://
www.cdc.gov/hicpac/.
DATES: The meeting will be held on May
16, 2019, 9:00 a.m. to 5:00 p.m., EDT,
and May 17, 2019, 9:00 a.m. to 12:00
p.m., EDT.
ADDRESSES: Centers for Disease Control
and Prevention, Global Communications
Center, Building 19, Auditorium B, 1600
Clifton Road NE, Atlanta, Georgia
30329–4027 and teleconference at 888–
455–9748, passcode: 4373458.
FOR FURTHER INFORMATION CONTACT: KooWhang Chung, M.P.H., HICPAC,
Division of Healthcare Quality
Promotion, NCEZID, CDC, l600 Clifton
Road NE, Mailstop H16–3, Atlanta,
Georgia 30329–4027 Telephone (404)
498–0730. Email: hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, and the Secretary,
Health and Human Services, regarding
(1) the practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
11977
of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Considered: The agenda
will include updates on CDC’s activities
for prevention of healthcare-associated
infections. It will also include updates
from the following HICPAC workgroups:
The Healthcare Personnel Guideline
Workgroup and the Neonatal Intensive
Care Unit (NICU) Guideline Workgroup.
The agenda also includes updates on
CDC and DHQP activities. Agenda items
are subject to change as priorities
dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–06088 Filed 3–28–19; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Mine Safety and
Health Research Advisory Committee
(MSHRAC)
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
MSHRAC, NIOSH. The MSHRAC
consists of 13 experts in fields
associated with mining safety and
health. Nominations are being sought
for individuals who have expertise and
qualifications necessary to contribute to
the accomplishments of the committee’s
objectives. Nominees will be selected
based on expertise in the fields of
mining safety and health, such as
mining engineering, industrial hygiene,
occupational safety and health
engineering, chemistry, safety and
health education, ergonomics,
epidemiology, statistics, and
psychology. Federal employees will not
be considered for membership.
Members may be invited to serve for up
to four-year terms. Selection of members
is based on candidates’ qualifications to
contribute to the accomplishment of
MSHRAC’s objectives.
SUMMARY:
E:\FR\FM\29MRN1.SGM
29MRN1
]]>Agencies
[Federal Register Volume 84, Number 61 (Friday, March 29, 2019)]
[Notices]
[Page 11977]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06088]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Healthcare Infection Control
Practices Advisory Committee (HICPAC). This meeting is open to the
public, is limited only by room seating available, (120). The public is
also welcome to listen to the meeting via teleconference at 888-455-
9748, passcode: 4373458; 100 teleconference lines are available. Time
will be available for public comment. The public is welcome to submit
written comments in advance of the meeting. Comments should be
submitted in writing by email to the contact person listed below. The
deadline for receipt of written public comment is May 2, 2019. All
requests must contain the name, address, and organizational affiliation
of the speaker, as well as the topic being addressed. Written comments
should not exceed one single-spaced typed page in length and delivered
in 3 minutes or less. Members of the public who wish to provide public
comments should plan to attend the public comment session at the start
time listed. Please note that the public comment period may end before
the time indicated, following the last call for comments. Written
comments received in advance of the meeting will be included in the
official record of the meeting. Registration is required to attend in
person or on the phone. Interested parties must be processed in
accordance with established federal policies and procedures and may
register at https://www.cdc.gov/hicpac/.
DATES: The meeting will be held on May 16, 2019, 9:00 a.m. to 5:00
p.m., EDT, and May 17, 2019, 9:00 a.m. to 12:00 p.m., EDT.
ADDRESSES: Centers for Disease Control and Prevention, Global
Communications Center, Building 19, Auditorium B, 1600 Clifton Road NE,
Atlanta, Georgia 30329-4027 and teleconference at 888-455-9748,
passcode: 4373458.
FOR FURTHER INFORMATION CONTACT: Koo-Whang Chung, M.P.H., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton
Road NE, Mailstop H16-3, Atlanta, Georgia 30329-4027 Telephone (404)
498-0730. Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion
(DHQP), the Director, National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), the Director, CDC, and the Secretary,
Health and Human Services, regarding (1) the practice of healthcare
infection prevention and control; (2) strategies for surveillance,
prevention, and control of infections, antimicrobial resistance, and
related events in settings where healthcare is provided; and (3)
periodic updating of CDC guidelines and other policy statements
regarding prevention of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Considered: The agenda will include updates on CDC's
activities for prevention of healthcare-associated infections. It will
also include updates from the following HICPAC workgroups: The
Healthcare Personnel Guideline Workgroup and the Neonatal Intensive
Care Unit (NICU) Guideline Workgroup. The agenda also includes updates
on CDC and DHQP activities. Agenda items are subject to change as
priorities dictate.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-06088 Filed 3-28-19; 8:45 am]
BILLING CODE 4163-19-P
